BAY HARBOR ISLAND, FL--(Marketwired - Jan 22, 2016) - Biotech Products Services & Research, Inc. (OTCQB: BPSR) (“Biotech” or the “Company”) is proud to announce the launch of its wholly-owned subsidiary, General Surgical Florida, Inc. (“General Surgical”).
The team at General Surgical will work towards establishing sales distribution channels of regenerative products to hospitals, physicians and third party distributors. Specifically, General Surgical will be providing access to advanced regenerative medical technologies (e.g., adipocyte, bone marrow and placental regenerative tissues), and expanding education services to providers in the Company’s referral network.
Albert Mitrani, Biotech’s CEO, commented, “This new branch of Biotech, we believe, will increase the depth of the patient referral network in our associated Beyond Cells subsidiary, as well as set the stage for sales and distribution of future product lines. We look forward to providing further information about General Surgical as developments occur.”
About Biotech Products Services & Research, Inc.
Biotech Products Services & Research Inc., a Nevada corporation, focuses on a lifestyle of health and wellness. Our vision is to be a vertically integrated company, which primarily provides a patient referral service for integrative cellular therapies. Biotech also markets cellular products to doctors and hospitals.
Biotech aims to be the leader in the industry of innovative cell-based therapeutic with our unique strategy which will guide a future of customized disease management. Biotech also sells women’s fashion products through its Ethan New York subsidiary as part of our vertically integrated health and wellness vision. For more information investors can visit www.bpsrhealth.com.
